Atossa Therapeutics
ATOS
#9205
Rank
ยฃ79.58 M
Marketcap
ยฃ0.62
Share price
-8.82%
Change (1 day)
-32.08%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -ยฃ21.8 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ19.05 Million, an increase over its 2023 earnings that were of -ยฃ22.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ21.8 Million14.44%
2024 -ยฃ19.05 Million-15.25%
2023 -ยฃ22.48 Million11.62%
2022 -ยฃ20.14 Million30.84%
2021 -ยฃ15.39 Million15.58%
2020 -ยฃ13.32 Million3.41%
2019 -ยฃ12.88 Million51.16%
2018 -ยฃ8.52 Million40.41%
2017 -ยฃ6.07 Million27.54%
2016 -ยฃ4.76 Million-47.49%
2015 -ยฃ9.06 Million-17.25%
2014 -ยฃ10.95 Million35.91%
2013 -ยฃ8.06 Million112.3%
2012 -ยฃ3.8 Million46.53%
2011 -ยฃ2.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.19 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ0.99 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ0.96 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.86 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.12 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ81.56 Million 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA